Product Information

TIZANIDINE HCL 4 MG CAPSULE is a generic product labeled by Advagen Pharma Ltd., priced at $0.1013 per EA under NDC 72888000215. Its NADAC has been published 279 times since Jul 14, 2021.

FDA first approved this application on May 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TIZANIDINE HCL 4 MG CAPSULE

tizanidine hydrochloride
$0.1013per EA

Strength

4 mg/1

NDC

72888000215

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TIZANIDINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213798

FDA Approved

5/27/2020

TE Code

AB

On Market Since

5/27/2020

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for TIZANIDINE HCL 4 MG CAPSULE has been published 279 times since Jul 14, 2021, and over the history we have for it it has declined 64.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1013 per EA
All-time high$0.2858 (Jul 14, 2021)
All-time low$0.0827 (May 22, 2024)
52-week high$0.1036
52-week low$0.0846
Median price$0.1274
Average price$0.1337
Largest weekly change+49.0% (Feb 23, 2022)
Weeks tracked279
Tracking sinceJul 14, 2021

Price History

1W

0.0%

1M

+4.7%

3M

+10.6%

6M

+16.5%

1Y

-13.0%

3Y

-21.1%

5Y

-55.4%

All

-64.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIZANIDINE HCL 4 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 4 MG CAPSULE, manufactured by Advagen Pharma Ltd., is $0.1013 per EA (NDC 72888000215), effective Nov 11, 2026.

How has the price of TIZANIDINE HCL 4 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has declined 64.6%. It has been tracked across 279 weekly CMS publications since Jul 14, 2021.

What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 4 MG CAPSULE?

Since Jul 14, 2021, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has ranged from a low of $0.0827 (May 22, 2024) to a high of $0.2858 (Jul 14, 2021), with a median of $0.1274 per EA.

Are there cheaper alternatives to TIZANIDINE HCL 4 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TIZANIDINE HCL 4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TIZANIDINE HCL 4 MG CAPSULE?

TIZANIDINE HCL 4 MG CAPSULE (NDC 72888000215) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.